FADS1/2 control lipid metabolism and ferroptosis susceptibility in triple-negative breast cancer.
Lorito N, Subbiani A, Smiriglia A, Bacci M, Bonechi F, Tronci L, Romano E, Corrado A, Longo DL, Iozzo M, et al. EMBO Mol Med. 2024 Jul; 16(7):1533-1559. Epub 2024 Jun 26.